(Q67263690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

Toxicity of oral adjuvant chemotherapy in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

1 reference

10.1136/BMJ.1.6110.408-A

https://api.crossref.org/works/10.1136/BMJ.1.6110.408-A

14 August 2023

author name string

J. G. Murray

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A624031

16 July 2022

J. MacIntyre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A624031

16 July 2022

D. P. Leiberman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A624031

16 July 2022

D. J. Leaper

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A624031

16 July 2022

language of work or name

English

0 references

publication date

1 February 1978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

18 February 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=624031

full work available at URL

16 July 2022

number of pages

2

1 reference

based on heuristic

inferred from page(s)

https://europepmc.org/articles/PMC1603020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A624031

https://europepmc.org/articles/PMC1603020?pdf=render

16 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A624031

https://syndication.highwire.org/content/doi/10.1136/bmj.1.6110.408-a

16 July 2022

1 reference

Crossref

DOI

10.1136/BMJ.1.6110.408-A

https://api.crossref.org/works/10.1136/BMJ.1.6110.408-A

14 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

6110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

408-409

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

L-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)

11 September 2019

cites work

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/624031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The CMF program for operable breast cancer with positive axillary nodes:Updated analysis on the disease-free interval, site of relapse and drug tolerance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/624031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.1.6110.408-A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:624031%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference